Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonnie L Hylander

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Immunological Investigations|August 19, 2006
The potential of the tumor microenvironment to influence Apo2L/TRAIL induced apoptosisThomas A Mace, Nariyuke Yamane, Jinrong Cheng, et al.
Frontiers in Immunology|February 27, 2018
Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune ResponseGuanxi Qiao, Minhui Chen, Mark J Bucsek, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 3, 2018
An overview of the role of sympathetic regulation of immune responses in infectious disease and autoimmunityMark J Bucsek, Thejaswini Giridharan, Cameron R MacDonald, et al.
Cancer Research|October 18, 2002
Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID miceTakuji Naka, Kenji Sugamura, Bonnie L Hylander, et al.
Oncology|August 21, 2008
Synergism of CPT-11 and Apo2L/TRAIL against two differentially sensitive human colon tumor xenograftsKenji Sugamura, John F Gibbs, Alan Belicha-Villanueva, et al.
Plos One|March 21, 2015
Defining immunological impact and therapeutic benefit of mild heating in a murine model of arthritisChen-Ting Lee, Kathleen M Kokolus, Nicholas D Leigh, et al.
Journal of Translational Medicine|June 10, 2005
The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID miceBonnie L Hylander, Rose Pitoniak, Remedios B Penetrante, et al.
Journal of Translational Medicine|May 4, 2013
Origin of the vasculature supporting growth of primary patient tumor xenograftsBonnie L Hylander, Natalie Punt, Haikuo Tang, et al.
Cancer Immunology, Immunotherapy : CII|October 14, 2014
A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic responseJason W-L Eng, Kathleen M Kokolus, Chelsey B Reed, et al.
Pancreas|February 13, 2014
Influence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L/TRAIL therapyRohit Sharma, Sandra Buitrago, Rose Pitoniak, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Immunological Investigations|August 19, 2006
The potential of the tumor microenvironment to influence Apo2L/TRAIL induced apoptosisThomas A Mace, Nariyuke Yamane, Jinrong Cheng, et al.
Frontiers in Immunology|February 27, 2018
Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune ResponseGuanxi Qiao, Minhui Chen, Mark J Bucsek, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 3, 2018
An overview of the role of sympathetic regulation of immune responses in infectious disease and autoimmunityMark J Bucsek, Thejaswini Giridharan, Cameron R MacDonald, et al.
Cancer Research|October 18, 2002
Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID miceTakuji Naka, Kenji Sugamura, Bonnie L Hylander, et al.
Oncology|August 21, 2008
Synergism of CPT-11 and Apo2L/TRAIL against two differentially sensitive human colon tumor xenograftsKenji Sugamura, John F Gibbs, Alan Belicha-Villanueva, et al.
Plos One|March 21, 2015
Defining immunological impact and therapeutic benefit of mild heating in a murine model of arthritisChen-Ting Lee, Kathleen M Kokolus, Nicholas D Leigh, et al.
Journal of Translational Medicine|June 10, 2005
The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID miceBonnie L Hylander, Rose Pitoniak, Remedios B Penetrante, et al.
Journal of Translational Medicine|May 4, 2013
Origin of the vasculature supporting growth of primary patient tumor xenograftsBonnie L Hylander, Natalie Punt, Haikuo Tang, et al.
Cancer Immunology, Immunotherapy : CII|October 14, 2014
A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic responseJason W-L Eng, Kathleen M Kokolus, Chelsey B Reed, et al.
Pancreas|February 13, 2014
Influence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L/TRAIL therapyRohit Sharma, Sandra Buitrago, Rose Pitoniak, et al.
Pageof 4